Theravance Biopharma to Present Clinical Data on TD1473 at the 12th Congress of the European Crohn's and Colitis Organization

DUBLIN Feb. 13 2017 PRNewswire Theravance Biopharma Inc. NASDAQ TBPH "Theravance Biopharma" or the "Company" today announced that it will highlight clinical data on TD1473 a novel potent and orally administered panJanus kinase JAK inhi...